JD Health International (JDHIF)

Overall impact
C (57)

Commentary

JD Health International is an average overall performer. With a 'C' rating of 56.9 for overall impact (56th percentile compared to all companies), JD Health International ranks 5th out of 15 industry peers, behind Australian Pharmaceutical Industries, Paragon Care, Sigma Healthcare and 1 other, and ahead of PetIQ, EBOS Group, Suzuken Co. and 7 others. On top material causes for JD Health International's industry (Healthcare Equipment), JD Health International performs poorly in Sanitation Access (39.0 score). JD Health International did not receive an 'A' rating on any cause.
Impact
Cause JDHIF
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company

JD Health International

Employees
6,018
Sector
Health Care
Industry
Health Care Providers & Services
Sub-industry
Health Care Distributors
SASB industry
Healthcare Distributors
Headquarters
China
Share classes
JDHIF
JDHIY
ADR
Description
JD Health International Inc., an investment holding company, engages in the operation of an online healthcare platform in the People's Republic of China. It provides online medical consultation, hospital or doctor referral, health check-ups, genetic testing, and beauty care services, as well as internet healthcare, health management, intelligent healthcare, advertising, and technical services. The company also offers home care services, including wound care, blood tests and diagnostics, post-operative care, and medical escort; online medical insurance payment services; and smart healthcare and digital health solutions. In addition, it provides online marketing services to advertisers; and online shopping and hospital services. Further, the company offers smart monitoring and respiratory therapy devices; senior-oriented medical devices; home medical device set-up and support services, including blood glucose meters and oxygen generators; and rapid testing products. Additionally, it provides traditional Chinese medicine (TCM) wellness and professional orthopedic services, as well as operates offline examination and polyclinic centers that offers convenient and professional healthcare services. The company offers pharmaceutical and healthcare products through direct sales, and online marketplace and on-demand retail businesses. It serves pharmaceutical and healthcare product companies. JD Health International Inc. was founded in 2014 and is headquartered in Beijing, the People's Republic of China. JD Health International Inc. is a subsidiary of JD Jiankang Limited.
Material causes
Ethos considers the following causes material for JD Health International, based on its industry sub-industry Health Care Distributors. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.